These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. Nishida T; Hudecek M; Kostic A; Bleakley M; Warren EH; Maloney D; Storb R; Riddell SR Clin Cancer Res; 2009 Jul; 15(14):4759-68. PubMed ID: 19567591 [TBL] [Abstract][Full Text] [Related]
5. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389 [TBL] [Abstract][Full Text] [Related]
6. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014 [TBL] [Abstract][Full Text] [Related]
9. [Allogeneic hematopoietic stem cell transplantation for solid tumors]. Kanda Y Rinsho Ketsueki; 2004 Mar; 45(3):189-94. PubMed ID: 15103931 [No Abstract] [Full Text] [Related]
10. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation]. Hudecek M; Bartsch K; Tschiedel S; Niederwieser D Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211 [TBL] [Abstract][Full Text] [Related]